← Eichor
Study identifier: NCT07089524 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis

Condition: Sepsis  ·  Sponsor: Ain Shams University

PhaseN/A
Planned participants160
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Aim of this study is to predict the prognostic values of Neutrophil/ Lymphocyte ratio and Lactate/Albumin ratio in the outcome of patients with sepsis and septic shock with lower respiratory tract infection, also to compare between them regarding sensitivity and specificity.

This description comes directly from the study's public registry record.

Talk to the study team

Ahmed Gamal Ahmed, M.BB.CH,M.Sc  ·  01141164417  ·  ahmed_gamal@med.asu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Ain Shams universityCairo, Abbassia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07089524